Catalan-Griffiths, AndreaPasquali, PaolaArias Santiago, SalvadorValerón, PedroMartínez López, AntonioNegrin, Maria LuzThuissard Vasallo, Israel JohnAndreu Vázquez, CristinaFreites Martínez, Azael David2024-05-192024-05-192023Catalan-Griffiths, A., Pasquali, P., Arias-Santiago, S., Valeron, P., Martínez-López, A., Negrin, M. L., Thuissard Vasallo, I. J., Andreu-Vazquez, C., & Freites-Martínez, A. (2023). Shared decision-making quality and decisional regret in patients with low-risk superficial basal cell carcinoma: A prospective, multicenter cohort study. JAAD Internacional, 13, 159-163. https://doi.org/10.1016/j.jdin.2023.05.0152666-3287http://hdl.handle.net/11268/12839To assess the SDM process of patients and physicians when deciding lr-sBCC therapy as well as the factors that may influence the SDM process. Methods: A prospective, multicenter cohort study was conducted over 18 months, from October 2018 to April 2020, in 3 tertiary university hospitals and 1 private hospital. Results: This study included 107 patients. There was a weak positive correlation between Shared Decision-Making Questionnaire-Patient version (SDM-Q-9) and Shared Decision-Making Questionnaire-Physician version (SDM-Q-Doc) (Spearman's correlation coefficient [rs] [105] = 0.21; P = .03). Most patients (71%) chose a nonsurgical treatment after the SDM process. Patients with higher satisfaction with the SDM had lower decisional conflict and decisional regret (P < .001). Patients aged >80 years had higher rates of significant decisional conflict. Conclusion: This study suggests that some patients may prefer less invasive therapies for lr-sBCC. The SDM process may reduce decisional conflict and decisional regret.engAttribution-NonCommercial-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/DermatologíaOncología medicajournal article10.1016/j.jdin.2023.05.015open accessCiencias médicas